Altitude Crest Partners Inc. Portfolio Holdings

Altitude Crest Partners Inc.

  • $234 Billion
  • Q1 2024

Altitude Crest Partners Inc. has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $234 Billion distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Legend Biotech Corp with a value of $36.6B, Danaher Corp with a value of $27.1B, Bridge Bio Pharma, Inc. with a value of $18.9B, Stevanato Group S.P.A. with a value of $17.7B, and Apellis Pharmaceuticals, Inc. with a value of $16.9B.

Examining the 13F form we can see an increase of $84.1B in the current position value, from $149B to 234B.

Altitude Crest Partners Inc. is based out at Stamford, CT

Below you can find more details about Altitude Crest Partners Inc. portfolio as well as his latest detailed transactions.

Portfolio value $234 Billion
Healthcare: $198 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$7.41B
$36.6 Billion 15.67% of portfolio
652,732
Q1 2024 Added 20.47%
$182B
$27.1 Billion 11.62% of portfolio
108,700
Q1 2024 Reduced 10.61%
$3.76B
$18.9 Billion 8.1% of portfolio
612,060
Q1 2024 Reduced 18.89%
$4.85B
$17.7 Billion 7.56% of portfolio
550,000
Q1 2024 New
$4.21B
$16.9 Billion 7.23% of portfolio
287,277
Q1 2024 Added 88.75%
$217B
$10.7 Billion 4.58% of portfolio
18,400
Q1 2024 New
Arrivent Biopharma Inc
-
$9.92 Billion 4.25% of portfolio
-
Q1 2024 New
Structure Therapeutics Inc
-
$8.79 Billion 3.76% of portfolio
-
Q1 2024 New
$644M
$7.9 Billion 3.38% of portfolio
400,441
Q1 2024 Reduced 12.19%
$1.75B
$7.28 Billion 3.12% of portfolio
193,300
Q1 2024 New
$860B
$7.16 Billion 3.06% of portfolio
9,200
Q1 2024 New
Biohaven LTD
-
$6.47 Billion 2.77% of portfolio
-
Q1 2024 New
$147M
$6.47 Billion 2.77% of portfolio
262,284
Q1 2024 New
$2.35B
$6.34 Billion 2.71% of portfolio
128,842
Q1 2024 New
$1.6B
$5.05 Billion 2.16% of portfolio
1,531,400
Q1 2024 New
$25.6B
$4.97 Billion 2.13% of portfolio
14,800
Q1 2024 New
$7.45B
$4.79 Billion 2.05% of portfolio
454,766
Q1 2024 Reduced 43.72%
$3.12B
$4.3 Billion 1.84% of portfolio
209,613
Q1 2024 New
Corbus Pharmaceuticals Hldgs
-
$4.07 Billion 1.74% of portfolio
-
Q1 2024 New
$2.36B
$3.31 Billion 1.42% of portfolio
113,100
Q1 2024 New
$1.01B
$3.23 Billion 1.38% of portfolio
195,497
Q1 2024 New
$13.9M
$2.79 Billion 1.19% of portfolio
2,844,681
Q4 2023 New
Engene Holdings Inc
-
$2.04 Billion 0.87% of portfolio
-
Q1 2024 New
$224M
$1.77 Billion 0.76% of portfolio
259,700
Q1 2024 New
Zymeworks Inc
-
$1.53 Billion 0.66% of portfolio
-
Q1 2024 New
Metagenomi Inc
-
$1.41 Billion 0.6% of portfolio
-
Q1 2024 New
Tourmaline Bio Inc
-
$1.09 Billion 0.46% of portfolio
-
Q1 2024 New
$29.9B
$29.9 Million 0.01% of portfolio
200
Q1 2024 New
$0
$12.5 Million 0.01% of portfolio
384,573
Q4 2023 New

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $234 Billion
  • Prior Value $149 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 14, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 22 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Altitude Crest Partners Inc. Portfolio

Follow Altitude Crest Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altitude Crest Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altitude Crest Partners Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email